You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Patent: RE42704


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE42704
Title:Production of fibrinogen in transgenic animals
Abstract: Materials and methods for producing fibrinogen in transgenic non-human mammals are disclosed. DNA segments encoding A.alpha., B.beta. and .gamma. chains of fibrinogen are introduced into the germ line of a non-human mammal, and the mammal or its female progeny produces milk containing fibrinogen expressed from the introduced DNA segments. Non-human mammalian embryos and transgenic non-human mammals carrying DNA segments encoding heterologous fibrinogen polypeptide chains are also disclosed.
Inventor(s): Prunkard; Donna E. (Seattle, WA), Foster; Donald C. (Lake Forest Park, WA)
Assignee: Pharming Intellectual Property B.V. (Al Leiden, NL)
Application Number:09/232,488
Patent Claims:see list of patent claims

Details for Patent RE42704

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Csl Behring Gmbh RIASTAP fibrinogen concentrate (human) For Injection 125317 01/16/2009 ⤷  Try a Trial 2040-01-28
Octapharma Pharmazeutika Produktionsges.m.b.h. FIBRYGA, FIBRYNA fibrinogen (human) For Injection 125612 06/07/2017 ⤷  Try a Trial 2040-01-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.